Journal
NUCLEUS
Volume 6, Issue 4, Pages 261-265Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/19491034.2015.1074365
Keywords
Akt; cell cycle; cell signaling; DNA repair; HR; NHEJ; Oncogene; phophorylation; signaling; tumorigenesis; XLF
Categories
Funding
- NIH [R01CA177910, R01GM094777]
- [1K99CA181342]
Ask authors/readers for more resources
To maintain genome stability, mammalian cells have developed a delicate, yet efficient, system to sense and repair damaged DNA, including two evolutionarily conserved DNA damage repair (DDR) pathways: homologous recombination (HR) and non-homologous-end-joining (NHEJ). Deregulation in these repair pathways may lead to genomic instability and subsequent human diseases, including cancer. On the other hand, hyper-activation of the oncogenic Akt signaling pathway has been observed in almost all solid tumors. Emerging evidence has begun to reveal a possible role of active Akt in regulating DDR, possibly through suppression of HR. However, whether and how Akt regulates NHEJ remains largely undefined. To this end, we recently reported that Akt impairs NHEJ by phosphorylating XLF at T181, to trigger its dissociation from the functional DNA ligase IV (LIG4)/XRCC4 complex. Here, we provide an additional perspective discussing how Akt is activated upon DNA damage to regulate DNA repair pathways as well as the cellular apoptotic responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available